Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40010438
Localisation
United States of America
Northern America
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
10/07/2025
Statut
Classification
1.5°C
Année cible
FY2030
Statut
Targets set
Classification
1.5°C
Année cible
FY2045
Overall Net-Zero Target: PCI Pharma Services commits to reach net-zero greenhouse gas emissions across the value chain by FY2045. Near-Term Targets: PCI Pharma Services commits to reduce absolute scope 1 and 2 GHG emissions 47.7% by FY2030 from a FY2023 base year. PCI Pharma Services also commits to reduce absolute scope 3 GHG emissions 25% by FY2030 from a FY2024 base year. Long-Term Targets: PCI Pharma Services commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2040 from a FY2023 base year. PCI Pharma Services also commits to reduce absolute scope 3 GHG emissions 90% by FY2045 from a FY2024 base year.
Statut
Targets setAnnée cible
FY2045
Statut
BA1.5 memberDate d'engagement
29/09/2022
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
549300KFNOGZK02UIC66
Expired commitment
Source : Science Based Targets initiative | Données publiques